Literature DB >> 1700523

Changes in serum proteins (albumin, immunoglobulins and acute phase proteins) in pulmonary tuberculosis during therapy.

C T Wong1, N Saha.   

Abstract

Serum levels of three immunoglobulins (IgG, IgA & IgM), albumin and six acute phase proteins (alpha 1-antitrypsin, haptoglobin, transferrin, alpha 2-macroglobulin, complements C3 & C4) were measured by immunoelectrophoresis in 57 patients with pulmonary tuberculosis when they were first diagnosed, and followed at 1 month, 2 month and 4 month intervals during anti-tuberculosis treatment. These values were compared to those from 41 healthy controls. Significant increases were observed in the initial values of serum IgG, IgM, alpha 1-antitrypsin and haptoglobin, while transferrin and alpha 2-macroglobulin levels were significantly reduced. No changes were observed in the levels of serum albumin, IgA and complement C3. Levels of all measured proteins decreased with treatment. However, at 4 months, IgG and alpha 1-antitrypsin were still significantly elevated when compared to control values, while the level of haptoglobin had decreased to a level significantly lower than that of the control value.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700523     DOI: 10.1016/0041-3879(90)90075-j

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  7 in total

1.  Anemia in hospitalized patients with pulmonary tuberculosis.

Authors:  Marina Gribel Oliveira; Karina Neves Delogo; Hedi Marinho de Melo Gomes de Oliveira; Antonio Ruffino-Netto; Afranio Lineu Kritski; Martha Maria Oliveira
Journal:  J Bras Pneumol       Date:  2014 Jul-Aug       Impact factor: 2.624

2.  Immunodiagnosis of tuberculosis: An update.

Authors:  A S Bhatia; Satish Kumar; B C Harinath
Journal:  Indian J Clin Biochem       Date:  2003-07

Review 3.  Avoidance and management of adverse reactions to antituberculosis drugs.

Authors:  A M Patel; J McKeon
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

4.  Proteomic profiling of serum from patients with tuberculosis.

Authors:  Sang Hoon Song; Minje Han; Yang Seon Choi; Ki Soon Dan; Man Gil Yang; Junghan Song; Sung Sup Park; Jae Ho Lee
Journal:  Ann Lab Med       Date:  2014-08-21       Impact factor: 3.464

5.  Acute Phase Proteins Are Baseline Predictors of Tuberculosis Treatment Failure.

Authors:  Nathella Pavan Kumar; Kadar Moideen; Arul Nancy; Vijay Viswanathan; Kannan Thiruvengadam; Shanmugam Sivakumar; Syed Hissar; Hardy Kornfeld; Subash Babu
Journal:  Front Immunol       Date:  2021-11-15       Impact factor: 7.561

6.  Unbalanced serum immunoglobulins in clinical subtypes of pediatric tuberculosis disease.

Authors:  Filippo Consonni; Nicolò Chiti; Silvia Ricci; Elisabetta Venturini; Clementina Canessa; Leila Bianchi; Francesca Lippi; Carlotta Montagnani; Mattia Giovannini; Elena Chiappini; Luisa Galli; Chiara Azzari; Lorenzo Lodi
Journal:  Front Pediatr       Date:  2022-08-09       Impact factor: 3.569

Review 7.  Albumin Infusion in Critically Ill COVID-19 Patients: Hemodilution and Anticoagulation.

Authors:  Giuliano Ramadori
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.